FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065135146> ?p ?o ?g. }

• W2065135146 endingPage "109" @default.
• W2065135146 startingPage "105" @default.
• W2065135146 abstract "Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG). Median age was 41 (range 11–70). Sixteen patients had AML that was primary resistant to induction treatment, while 22 were relapsed, 11 after autologous bone marrow transplant (AuBMT), 8 less than 6 months from complete remission (CR) achievement, and 3 were second relapse from chemotherapy alone. Overall, 21 of 38 patients (55%) obtained CR. Age, sex, length of CR, and interval between autoBMT and FLAG administration did not significantly influence the CR rate. On the contrary, a normal karyotype at diagnosis was significantly related to a better outcome. There were 4 induction deaths (10%), due to fungal infection in 2 patients and hemorrhagic complications in the remaining two. All patients experienced profound cytopenia. Median time to neutrophil (>500/μl) recovery was 21 days, while a platelet count >20,000/μl was reached after 23 days. The median period of hospitalization was 31 days. The nonhematological toxicity was mild, mainly consisting of mucositis. There were 17 documented infections and 17 episodes of fever of unknown origin. Following CR achievement, 6 patients received autoBMT, 3 alloBMT, 2 high-dose arabinosil-cytosine, and 2 are on a waiting list for transplantation procedure. We conclude that FLAG is an effective and well-tolerated regimen for refractory or recurrent AML, mainly useful for patients to be admitted to bone marrow transplantation. Am. J. Hematol. 58:105–109, 1998. © 1998 Wiley-Liss, Inc." @default.
• W2065135146 created "2016-06-24" @default.
• W2065135146 creator A5002995578 @default.
• W2065135146 creator A5006023644 @default.
• W2065135146 creator A5008054206 @default.
• W2065135146 creator A5016753594 @default.
• W2065135146 creator A5030954458 @default.
• W2065135146 creator A5034356923 @default.
• W2065135146 creator A5039819830 @default.
• W2065135146 creator A5042609656 @default.
• W2065135146 creator A5042737027 @default.
• W2065135146 creator A5072941996 @default.
• W2065135146 date "1998-06-01" @default.
• W2065135146 modified "2023-10-05" @default.
• W2065135146 title "Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia" @default.
• W2065135146 cites W1591796471 @default.
• W2065135146 cites W1709114039 @default.
• W2065135146 cites W1798910287 @default.
• W2065135146 cites W1804439365 @default.
• W2065135146 cites W1819781110 @default.
• W2065135146 cites W1857665725 @default.
• W2065135146 cites W1881046587 @default.
• W2065135146 cites W1969474912 @default.
• W2065135146 cites W1970187492 @default.
• W2065135146 cites W2011564019 @default.
• W2065135146 cites W2070044750 @default.
• W2065135146 cites W2150113701 @default.
• W2065135146 cites W2160480581 @default.
• W2065135146 cites W2204518675 @default.
• W2065135146 cites W2256976419 @default.
• W2065135146 cites W4293241248 @default.
• W2065135146 doi "https://doi.org/10.1002/(sici)1096-8652(199806)58:2<105::aid-ajh3>3.0.co;2-w" @default.
• W2065135146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9625576" @default.
• W2065135146 hasPublicationYear "1998" @default.
• W2065135146 type Work @default.
• W2065135146 sameAs 2065135146 @default.
• W2065135146 citedByCount "121" @default.
• W2065135146 countsByYear W20651351462012 @default.
• W2065135146 countsByYear W20651351462013 @default.
• W2065135146 countsByYear W20651351462014 @default.
• W2065135146 countsByYear W20651351462015 @default.
• W2065135146 countsByYear W20651351462016 @default.
• W2065135146 countsByYear W20651351462017 @default.
• W2065135146 countsByYear W20651351462018 @default.
• W2065135146 countsByYear W20651351462019 @default.
• W2065135146 countsByYear W20651351462020 @default.
• W2065135146 countsByYear W20651351462021 @default.
• W2065135146 countsByYear W20651351462022 @default.
• W2065135146 countsByYear W20651351462023 @default.
• W2065135146 crossrefType "journal-article" @default.
• W2065135146 hasAuthorship W2065135146A5002995578 @default.
• W2065135146 hasAuthorship W2065135146A5006023644 @default.
• W2065135146 hasAuthorship W2065135146A5008054206 @default.
• W2065135146 hasAuthorship W2065135146A5016753594 @default.
• W2065135146 hasAuthorship W2065135146A5030954458 @default.
• W2065135146 hasAuthorship W2065135146A5034356923 @default.
• W2065135146 hasAuthorship W2065135146A5039819830 @default.
• W2065135146 hasAuthorship W2065135146A5042609656 @default.
• W2065135146 hasAuthorship W2065135146A5042737027 @default.
• W2065135146 hasAuthorship W2065135146A5072941996 @default.
• W2065135146 hasBestOaLocation W20651351461 @default.
• W2065135146 hasConcept C126322002 @default.
• W2065135146 hasConcept C136119220 @default.
• W2065135146 hasConcept C141071460 @default.
• W2065135146 hasConcept C202444582 @default.
• W2065135146 hasConcept C2776611710 @default.
• W2065135146 hasConcept C2776694085 @default.
• W2065135146 hasConcept C2776730729 @default.
• W2065135146 hasConcept C2776755627 @default.
• W2065135146 hasConcept C2777767877 @default.
• W2065135146 hasConcept C2778041864 @default.
• W2065135146 hasConcept C2778461978 @default.
• W2065135146 hasConcept C2778496288 @default.
• W2065135146 hasConcept C2778729363 @default.
• W2065135146 hasConcept C2779263901 @default.
• W2065135146 hasConcept C2780007613 @default.
• W2065135146 hasConcept C2780366003 @default.
• W2065135146 hasConcept C2781413609 @default.
• W2065135146 hasConcept C2911091166 @default.
• W2065135146 hasConcept C33923547 @default.
• W2065135146 hasConcept C71924100 @default.
• W2065135146 hasConcept C90924648 @default.
• W2065135146 hasConceptScore W2065135146C126322002 @default.
• W2065135146 hasConceptScore W2065135146C136119220 @default.
• W2065135146 hasConceptScore W2065135146C141071460 @default.
• W2065135146 hasConceptScore W2065135146C202444582 @default.
• W2065135146 hasConceptScore W2065135146C2776611710 @default.
• W2065135146 hasConceptScore W2065135146C2776694085 @default.
• W2065135146 hasConceptScore W2065135146C2776730729 @default.
• W2065135146 hasConceptScore W2065135146C2776755627 @default.
• W2065135146 hasConceptScore W2065135146C2777767877 @default.
• W2065135146 hasConceptScore W2065135146C2778041864 @default.
• W2065135146 hasConceptScore W2065135146C2778461978 @default.
• W2065135146 hasConceptScore W2065135146C2778496288 @default.
• W2065135146 hasConceptScore W2065135146C2778729363 @default.
• W2065135146 hasConceptScore W2065135146C2779263901 @default.
• W2065135146 hasConceptScore W2065135146C2780007613 @default.
• W2065135146 hasConceptScore W2065135146C2780366003 @default.

• next